Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for InfuSystems Holdings, Inc. (INFU : AMEX)

• Company Description    InfuSystem is a rapidly growing healthcare services company that provides state-of-the-art electronic continuous ambulatory infusion pumps, supplies and support to oncology practices and clinics throughout the United States. More than 60% of oncologists across all 50 states turn to InfuSystem as their single, full-service source for cost-effective infusion pump management. Number of Employees: 473

• Price / Volume Information    Yesterday's Closing Price: $9.62 Daily Weekly Monthly 20 Day Moving Average: 92,903 shares Shares Outstanding: 20.22 (millions) Market Capitalization: $194.47 (millions) Beta: 1.54 52 Week High: $11.04 52 Week Low: $4.66 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 2.45% 0.17% 12 Week 11.86% 13.82% Year To Date 7.25% 7.57%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 3851 West Hamlin Road - Rochester Hills,MI 48309 USA ph: 248-291-1210 fax: 800-455-4338 None http://www.infusystem.com

• General Corporate Information    Officers Carrie Lachance - Chief Executive Officer and Director Scott Shuda - Chairman Barry Steele - Chief Financial Officer Kenneth Eichenbaum - Director Paul Gendron - Director Peer Information InfuSystems Holdings, Inc. (BJCT) InfuSystems Holdings, Inc. (CADMQ) InfuSystems Holdings, Inc. (APNO) InfuSystems Holdings, Inc. (UPDC) InfuSystems Holdings, Inc. (IMTIQ) InfuSystems Holdings, Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 45685K102 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 12/01/25 Next Expected EPS Date: 05/14/26 Share - Related Items Shares Outstanding: 20.22 Most Recent Split Date: (:1) Beta: 1.54 Market Capitalization: $194.47 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.11 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.39 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 05/14/26

• Fundamental Ratios P/E Current FY Estimate: 24.67 Trailing 12 Months: 30.06 PEG Ratio: - Price Ratios Price/Book: 3.41 Price/Cash Flow: 9.78 Price / Sales: 1.36 EPS Growth vs. Year Ago Period: 150.00% vs. Previous Quarter: -9.09% Sales Growth vs. Year Ago Period: 7.04% vs. Previous Quarter: -0.71% ROE 03/31/26 - - 12/31/25 - 11.91 09/30/25 - 9.92 ROA 03/31/26 - - 12/31/25 - 6.55 09/30/25 - 5.42 Current Ratio 03/31/26 - - 12/31/25 - 1.80 09/30/25 - 1.90 Quick Ratio 03/31/26 - - 12/31/25 - 1.53 09/30/25 - 1.60 Operating Margin 03/31/26 - - 12/31/25 - 4.62 09/30/25 - 3.92 Net Margin 03/31/26 - - 12/31/25 - 4.62 09/30/25 - 3.92 Pre-Tax Margin 03/31/26 - - 12/31/25 - 7.41 09/30/25 - 6.66 Book Value 03/31/26 - - 12/31/25 - 2.82 09/30/25 - 2.72 Inventory Turnover 03/31/26 - - 12/31/25 - 11.10 09/30/25 - 10.55 Debt-to-Equity 03/31/26 - - 12/31/25 - 0.34 09/30/25 - 0.38 Debt-to-Capital 03/31/26 - - 12/31/25 - 25.50 09/30/25 - 27.40

Powered by Zacks Investment Research ©